SecBot SecBot
DEFA14A ·Filed May 5, 2026

HYPD

HYPERION DEFI, INC.
NEUTRAL
Impact 3/10
Horizondays Processed5mo ago SEC0001104659-26-055727
Proxy solicitation materials
Actionable Insight • Neutral

The proposals are routine and likely to pass. Monitor the vote outcome, especially the written consent amendment (Proposal 4), which could signal governance changes. No immediate trading action warranted.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d ⚠ clustered
HYPD ▼ -27.47% at T+60d
NEUTRAL call -27.47% · α vs SPY -29.53% · entry $3.64 → $2.64
Entry = T+0 close
May 5, 2026
via day close
T+1d
-1.92%
call -1.92% · α -1.59%
$3.57
settled 6mo ago
T+5d
-5.77%
call -5.77% · α -6.90%
$3.43
settled 6mo ago
T+20d
-0.82%
call -0.82% · α -3.61%
$3.61
settled 5mo ago
T+60d
-27.47%
call -27.47% · α -29.53%
$2.64
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

Hyperion DeFi filed definitive additional proxy materials (DEFA14A) for its 2026 Annual Meeting to be held virtually on June 30, 2026. Proposals include election of five directors, ratification of auditor, advisory say-on-pay, and an amendment to allow stockholder action by written consent. The board recommends a vote FOR all proposals.

Key Financial Metrics

Vote
director election
Meeting
2026-06-30

Key Facts

  • Annual Meeting scheduled for June 30, 2026, at 12:00 p.m. ET
  • Proposal 1: Elect five directors (Hyunsu Jung, Michael Geltzeiler, Rachel Jacobson, Happy Walters, Ellen Strahlman)
  • Proposal 2: Ratify CBIZ CPAs P.C. as auditor for FY2026
  • Proposal 3: Advisory vote on executive compensation
  • Proposal 4: Approve amendment to certificate of incorporation to allow stockholder action by written consent
  • Proposal 5: Adjourn meeting if necessary for further solicitation on Proposal 4
  • Board recommends FOR all proposals

Financial Impact

No financial impact from this filing

Risk Factors

  • Low voter turnout could delay approval of Proposal 4
  • No material financial risk from these proposals

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
88% bullish (8 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001104659-26-055727
Document: 0001104659-26-055727-index-headers.html0001104659-26-055727
Document: 0001104659-26-055727-index.html0001104659-26-055727
Document: 0001104659-26-055727.txt0001104659-26-055727
13 reports for HYPD
Performance horizon
75% Hit rate @ T+20 3 of 4 directional calls Went positive at some point 5 of 5 best @ T+60▲ +24.17%May 8, 2026
Filters
Rows
Reports for HYPD — sortable, filterable
TypeNow
Oct 19, 2026
8d ago
Press Release
NEUTRAL ★ 1/10
$2.86awaiting T+20—$2.85 (−0.35%)
Oct 5, 2026
21d ago
SC 13G/A
NEUTRAL ★ 2/10
$3.89awaiting T+20—$2.85 (−26.74%)
Oct 2, 2026
25d ago
8-K
BULLISH ★ 6/10
$3.73awaiting T+20—$2.85 (−23.59%)
Aug 12, 2026
10w ago
8-K
BULLISH ★ 7/10
$2.83 $3.49▲ +23.32%▲ +25.07%$2.85 (+0.71%)
Aug 12, 2026
10w ago
Press Release
BULLISH ★ 7/10
$2.83 $3.49▲ +23.32%▲ +25.07%$2.85 (+0.71%)
Jul 8, 2026
15w ago
8-K
NEUTRAL ★ 3/10
$2.97 $2.73▼ −8.08%▼ −11.35%$2.85 (−4.04%)
Jun 8, 2026
20w ago
Press Release
MIXED ★ 6/10
$2.93 $3.26▲ +11.26%▲ +9.63%$2.85 (−2.73%)
May 14, 2026
23w ago
8-K
BULLISH ★ 7/10
$3.62 $2.72▼ −24.86%▼ −24.00%$2.85 (−21.27%)
May 14, 2026
23w ago
Press Release
MIXED ★ 6/10
$3.62 $2.72▼ −24.86%▼ −24.00%$2.85 (−21.27%)
May 8, 2026
24w ago
Press Release
BEARISH ★ 6/10
$3.60 $2.99▲ +16.94%▲ +16.97%$2.85 (+20.83%)
Showing 10 of 13

US Market Status

Market Closed — Opens in 1h 5m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 5, 2026